MetLife, Inc. logo

MetLife, Inc.

MET-PF

NYSEFinancial ServicesInsurance - Life

Previous close

$17.97

−$0.12 · -0.66%

Aug 21, 4:00 PM ET

MET-PF company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

49

Fair Value

Momentum

39

Weakening

Sentiment

51

Mixed

Risk resilience

79

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

MetLife, Inc., a global financial services enterprise headquartered in New York, New York, and established in 1863, delivers a broad spectrum of solutions, encompassing insurance, annuities, employee benefits, and asset management services to clients worldwide. Its operations are structured across five key segments: the U.S., Asia, Latin America, Europe, the Middle East and Africa, and MetLife Holdings. MetLife's extensive insurance offerings include individual and group life, dental, vision, pet, accident and health, and accidental death and dismemberment coverages. It also provides various disability plans (short-term, long-term, and individual), prepaid legal services, and administrative services-only arrangements for corporate clients. Beyond traditional protection, the company offers a diverse portfolio of savings and investment vehicles. These range from fixed, indexed-linked, and variable annuities to pension and regular savings products. It manages general and separate account contracts, synthetic guaranteed interest contracts, and private floating rate funding agreements. MetLife also specializes in pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products. Further services include funding agreements for post-retirement benefits, along with company, bank, or trust-owned life insurance designed to finance non-qualified executive benefit programs. The product suite is rounded out by endowments, universal and variable life policies, group life insurance, longevity reinsurance, credit insurance, and long-term healthcare protection plans.

Industry
Insurance - Life
Sector
Financial Services
Headquarters
US
CEO
Michel Abbas Khalaf
Listed since
Jan 8, 2020
Employees
46,000

Market position

Day range

Current $17.97

52-week range

Current $17.97

Open
$18.12
Previous close
$18.09
Volume
81.19K
0.8× average
Average volume
101.99K
Average daily volume
Market cap
63.37B USD
Beta
0.76
Market reference 1
50-day average
$18.3385
-2.01% below average
200-day average
$19.111
-5.97% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
17.97×
P/B (TTM)
2.25×
P/S (TTM)
0.77×
Dividend yield
2.46%

Profitability & efficiency

Gross margin
25.55%
Operating margin
6.19%
Net margin
4.61%

Financial health

Debt / equity
0.74×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends40%26%13%-1%Gross margin, FY2021: 26.57%Gross margin, FY2022: 27.86%Gross margin, FY2023: 25.53%Gross margin, FY2024: 27.17%Gross margin, FY2025: 36.36%Operating margin, FY2021: 13.44%Operating margin, FY2022: 9.36%Operating margin, FY2023: 3.19%Operating margin, FY2024: 8.04%Operating margin, FY2025: 6.05%Net margin, FY2021: 10.82%Net margin, FY2022: 7.77%Net margin, FY2023: 2.33%Net margin, FY2024: 6.33%Net margin, FY2025: 4.38%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 26.57%. Gross margin FY2022 27.86%. Gross margin FY2023 25.53%. Gross margin FY2024 27.17%. Gross margin FY2025 36.36%. Operating margin FY2021 13.44%. Operating margin FY2022 9.36%. Operating margin FY2023 3.19%. Operating margin FY2024 8.04%. Operating margin FY2025 6.05%. Net margin FY2021 10.82%. Net margin FY2022 7.77%. Net margin FY2023 2.33%. Net margin FY2024 6.33%. Net margin FY2025 4.38%.

Income trends

Revenue

77.08B USD+10.22%

Operating income

4.66B USD-17.09%

Net income

3.38B USD-23.66%
Income trends across reported periods84.63B USD54.43B USD24.23B USD−5.97B USDRevenue, FY2021: 63.37B USDRevenue, FY2022: 67.97B USDRevenue, FY2023: 67.71B USDRevenue, FY2024: 69.94B USDRevenue, FY2025: 77.08B USDOperating income, FY2021: 8.52B USDOperating income, FY2022: 6.36B USDOperating income, FY2023: 2.16B USDOperating income, FY2024: 5.62B USDOperating income, FY2025: 4.66B USDNet income, FY2021: 6.86B USDNet income, FY2022: 5.28B USDNet income, FY2023: 1.58B USDNet income, FY2024: 4.43B USDNet income, FY2025: 3.38B USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 63.37B USD. Revenue FY2022 67.97B USD. Revenue FY2023 67.71B USD. Revenue FY2024 69.94B USD. Revenue FY2025 77.08B USD. Operating income FY2021 8.52B USD. Operating income FY2022 6.36B USD. Operating income FY2023 2.16B USD. Operating income FY2024 5.62B USD. Operating income FY2025 4.66B USD. Net income FY2021 6.86B USD. Net income FY2022 5.28B USD. Net income FY2023 1.58B USD. Net income FY2024 4.43B USD. Net income FY2025 3.38B USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue77.08B USD69.94B USD67.71B USD67.97B USD63.37B USD
Cost of goods sold49.06B USD50.94B USD50.42B USD49.03B USD46.53B USD
Gross profit28.02B USD19B USD17.29B USD18.94B USD16.84B USD
Selling, general, and administrative5.99B USD6.18B USD5.86B USD5.76B USD
Operating expenses23.36B USD13.38B USD15.13B USD12.57B USD8.32B USD
Interest expense1.06B USD1.04B USD1.05B USD938M USD920M USD
Depreciation and amortization753M USD714M USD718M USD673M USD694M USD
Operating income4.66B USD5.62B USD2.16B USD6.36B USD8.52B USD
Net income3.38B USD4.43B USD1.58B USD5.28B USD6.86B USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
45%
5 beats, 6 misses, 0 met estimates
Average EPS surprise
-4.55%
11 comparable reports
Latest EPS result
2.43
Estimate 2.3 · Beat by 5.65%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates2.652.392.121.86Q1 '25MissQ2 '25MissQ3 '25MissQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 5, 2025: actual 2.09, estimate 2.11, surprise -0.95%, Miss. Q2 2025, reported Apr 30, 2025: actual 1.96, estimate 2, surprise -2.00%, Miss. Q3 2025, reported Aug 4, 2025: actual 2.02, estimate 2.15, surprise -6.05%, Miss. Q4 2025, reported Nov 5, 2025: actual 2.34, estimate 2.32, surprise +0.86%, Beat. Q1 2026, reported Feb 4, 2026: actual 2.49, estimate 2.34, surprise +6.41%, Beat. Q2 2026, reported May 6, 2026: actual 2.42, estimate 2.27, surprise +6.61%, Beat. Q3 2026, reported Aug 5, 2026: actual 2.43, estimate 2.3, surprise +5.65%, Beat. Q4 2026, reported Nov 4, 2026: actual —, estimate 2.55, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates28.31B24.29B20.27B16.25BQ1 '25MissQ2 '25BeatQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 5, 2025: actual 18.67B USD, estimate 19.5B USD, surprise -4.30%, Miss. Q2 2025, reported Apr 30, 2025: actual 18.57B USD, estimate 18.37B USD, surprise +1.07%, Beat. Q3 2025, reported Aug 4, 2025: actual 17.34B USD, estimate 18.53B USD, surprise -6.45%, Miss. Q4 2025, reported Nov 5, 2025: actual 17.36B USD, estimate 18.8B USD, surprise -7.67%, Miss. Q1 2026, reported Feb 4, 2026: actual 23.81B USD, estimate 27.22B USD, surprise -12.51%, Miss. Q2 2026, reported May 6, 2026: actual 19.68B USD, estimate 19.49B USD, surprise +1.00%, Beat. Q3 2026, reported Aug 5, 2026: actual 19.08B USD, estimate 19.67B USD, surprise -3.00%, Miss. Q4 2026, reported Nov 4, 2026: actual —, estimate 20.1B USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

24 ratings
Strong buy14%
Buy1979%
Hold417%
Sell00%
Strong sell00%

MET-PF peers

ETFs holding MET-PF

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research MET-PF

research.disclaimer